Glaukos Announces Issuance of New U.S. Patent
SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, today announced that the United States Patent and Trademark Office has issued U.S. Patent No. 9,827,143 to the company. Entitled “Shunt Device and Method for Treating Ocular Disorders”, the newly issued patent covers ocular devices and methods of